109 related articles for article (PubMed ID: 34981466)
21. Microsatellite Instability and Altered Expressions of MLH1 and MSH2 in Gastric Cancer.
Haron NH; Mohamad Hanif EA; Abdul Manaf MR; Yaakub JA; Harun R; Mohamed R; Mohamed Rose I
Asian Pac J Cancer Prev; 2019 Feb; 20(2):509-517. PubMed ID: 30803214
[TBL] [Abstract][Full Text] [Related]
22. Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer.
Kanda M; Shimizu D; Tanaka H; Shibata M; Iwata N; Hayashi M; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Oncotarget; 2016 Mar; 7(12):13667-79. PubMed ID: 26872374
[TBL] [Abstract][Full Text] [Related]
23. Lysyl oxidase and hypoxia-inducible factor 1α: biomarkers of gastric cancer.
Han YL; Chen L; Qin R; Wang GQ; Lin XH; Dai GH
World J Gastroenterol; 2019 Apr; 25(15):1828-1839. PubMed ID: 31057297
[TBL] [Abstract][Full Text] [Related]
24. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
[TBL] [Abstract][Full Text] [Related]
25. [Expression level and prognostic value of PD-L1 in microsatellite instability-high gastric cancer].
Wang XY; Hu YJ; Dong K; Zhao C; Huang XZ; Lian SY; Sun Y
Zhonghua Bing Li Xue Za Zhi; 2020 Nov; 49(11):1114-1119. PubMed ID: 33152814
[No Abstract] [Full Text] [Related]
26. Identification of differentially expressed signatures of long non-coding RNAs associated with different metastatic potentials in gastric cancer.
Song W; Liu YY; Peng JJ; Liang HH; Chen HY; Chen JH; He WL; Xu JB; Cai SR; He YL
J Gastroenterol; 2016 Feb; 51(2):119-29. PubMed ID: 26045391
[TBL] [Abstract][Full Text] [Related]
27. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H
Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580
[TBL] [Abstract][Full Text] [Related]
28. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
Jin JJ; Dai FX; Long ZW; Cai H; Liu XW; Zhou Y; Hong Q; Dong QZ; Wang YN; Huang H
Oncol Rep; 2017 Jun; 37(6):3279-3286. PubMed ID: 28440473
[TBL] [Abstract][Full Text] [Related]
29. CUL4B promotes gastric cancer invasion and metastasis-involvement of upregulation of HER2.
Qi M; Jiao M; Li X; Hu J; Wang L; Zou Y; Zhao M; Zhang R; Liu H; Mi J; Zhang L; Liu L; Gong Y; Han B
Oncogene; 2018 Feb; 37(8):1075-1085. PubMed ID: 29106389
[TBL] [Abstract][Full Text] [Related]
30. miR-126: An indicator of poor prognosis and recurrence in histologically lymph node-negative gastric cancer.
Feng R; Sah BK; Li J; Lu S; Yuan F; Jin X; Yan M; Liu B; Li C; Zhu Z
Cancer Biomark; 2018; 23(3):437-445. PubMed ID: 30248047
[TBL] [Abstract][Full Text] [Related]
31. FBXO50 Enhances the Malignant Behavior of Gastric Cancer Cells.
Miwa T; Kanda M; Tanaka H; Tanaka C; Kobayashi D; Umeda S; Iwata N; Hayashi M; Yamada S; Fujii T; Fujiwara M; Kodera Y
Ann Surg Oncol; 2017 Nov; 24(12):3771-3779. PubMed ID: 28560594
[TBL] [Abstract][Full Text] [Related]
32.
Huang T; Liang Y; Zhang H; Chen X; Wei H; Sun W; Wang Y
Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828321
[TBL] [Abstract][Full Text] [Related]
33. LncRNA CTC-497E21.4 promotes the progression of gastric cancer via modulating miR-22/NET1 axis through RhoA signaling pathway.
Zong W; Feng W; Jiang Y; Cao Y; Ke Y; Shi X; Ju S; Cong H; Wang X; Cui M; Jing R
Gastric Cancer; 2020 Mar; 23(2):228-240. PubMed ID: 31451992
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the clinical significance of DNA methylation in gastric cancer based on a genome-wide high-resolution array.
Fang WL; Chen MH; Huang KH; Chang SC; Lin CH; Chao Y; Lo SS; Li AF; Wu CW; Shyr YM
Clin Epigenetics; 2019 Nov; 11(1):154. PubMed ID: 31675985
[TBL] [Abstract][Full Text] [Related]
35. Unique characteristics of
Kim YS; Jeong H; Choi JW; Oh HE; Lee JH
Saudi J Gastroenterol; 2017; 23(5):268-274. PubMed ID: 28937020
[TBL] [Abstract][Full Text] [Related]
36. miR-138 inhibits gastric cancer growth by suppressing SOX4.
Pang L; Li B; Zheng B; Niu L; Ge L
Oncol Rep; 2017 Aug; 38(2):1295-1302. PubMed ID: 28656304
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of increased expression of RBM8A in gastric cancer.
Lv X; Cheng H
Braz J Med Biol Res; 2020; 53(4):e9290. PubMed ID: 32294703
[TBL] [Abstract][Full Text] [Related]
38. The Association of HOTAIR with the Diagnosis and Prognosis of Gastric Cancer and Its Effect on the Proliferation of Gastric Cancer Cells.
Xu Z; Chen H; Yang B; Liu X; Zhou X; Kong H
Can J Gastroenterol Hepatol; 2019; 2019():3076345. PubMed ID: 31281803
[TBL] [Abstract][Full Text] [Related]
39. Circular RNA circCCDC9 acts as a miR-6792-3p sponge to suppress the progression of gastric cancer through regulating CAV1 expression.
Luo Z; Rong Z; Zhang J; Zhu Z; Yu Z; Li T; Fu Z; Qiu Z; Huang C
Mol Cancer; 2020 May; 19(1):86. PubMed ID: 32386516
[TBL] [Abstract][Full Text] [Related]
40. Causes and consequences of microsatellite instability in gastric carcinogenesis.
Velho S; Fernandes MS; Leite M; Figueiredo C; Seruca R
World J Gastroenterol; 2014 Nov; 20(44):16433-42. PubMed ID: 25469011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
